Sort
15,842 grants matching “pancreatic cancer”
THE EVOLUTION OF PGD ADDICTION IN HUMAN PANCREATIC CANCER
$225,786Oliver Gene McDonald · University Of Miami School Of Medicine · R01 · FY2024 · CA
Investigation of therapeutic modulators of apoptotic priming in pancreatic cancer
$225,765Anthony G Letai · Dana-Farber Cancer Inst · R21 · FY2014 · CA
Predicting the diagnosis of pancreatic cancer by leveraging big data
$225,588Christie Younghae Jeon · Cedars-Sinai Medical Center · R21 · FY2019 · CA
Visualizing Immune Responses in vivo: a systems biology approach
$225,544Dan Gabriel Duda · Massachusetts General Hospital · R21 · FY2009 · CA
Perivascular remodeling to enhance drug delivery in Pancreatic Cancer
$225,455Jiha Kim · North Dakota State University · P20 · FY2020 · GM
Electronic, exosome-based liquid biopsy in early state pancreatic cancer
$225,455Yongki Choi · North Dakota State University · P20 · FY2020 · GM
Identification of multi-omic marker associations in pancreatic cancer
$225,454Rick J Jansen · North Dakota State University · P20 · FY2020 · GM
X-ray studies of metalloenzyme regulation and catalysis
$225,428Massachusetts Institute Of Technology · R01 · FY2004 · GM
Defining the KRAS mutation specific interactions in pancreas cancer
$225,129Guy Hobbs · Medical University Of South Carolina · P20 · FY2021 · GM
Cost and Quality of Cancer Surgery
$225,112Vivian Ho · Rice University · R01 · FY2012 · CA
Development of targeted, safe and effective drugs against pancreatic ductal adenocarcinoma (PDAC) by leveraging a novel, comprehensive, computational drug discovery approach
$225,030Timothy S Heuer · Twoxar, Inc. · R43 · FY2018 · CA
Novel Tools for Familial Risk Prediction
$225,021Giovanni Parmigiani · Dana-Farber Cancer Inst · R21 · FY2013 · CA
Direct inhibition of mutant K-Ras for the treatment of cancer
$225,016Matt Patricelli · Wellspring Biosciences, Llc · R43 · FY2013 · CA
Mechanisms of RelA Activation in Cancer
$225,003Paul J Chiao · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Mechanisms of RelA Activation in Cancer
$225,003Paul J Chiao · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening
$225,001David Freedman · Nanoview Diagnostics, Inc. · R43 · FY2017 · CA
Replicating Tumor ECM in Microchannels for 3D Phenotypic HTS Assays
$225,000Robert Lowery · Bellbrook Labs, Llc · N43 · FY2014 · CA
Development of a suite of high-specificity fucose binding reagents
$225,000Loretta Yang · Lectenz Bio, Inc. · R43 · FY2021 · GM
Tobacco/nicotine, cytochrome P450, and HIV-1
$225,000Santosh Kumar · University Of Missouri Kansas City · R21 · FY2011 · DA
FrostBite - A Unique Catheter for Endoscopic Cryoablation
$225,000J M Baust · Cell Preservation Services, Inc. · R43 · FY2014 · CA
Development of a suite of high-specificity fucose binding reagents
$225,000Loretta Yang · Lectenz Bio, Inc. · R43 · FY2020 · GM
Development of an ADC against Pancreatic Cancer
$225,000Michael J Schlosser · Coare Biotechnology, Inc. · R43 · FY2015 · CA
STTR Phase I: An Endoscopic-Based INSPIRE Platform for Treating and Monitoring Unresectable Pancreatic Cancer
$225,000Michael Sano · Voltmed · · FY2014 · TIP
Mucins in the Diagnosis and Prognosis of Pancreatic Diseases
$225,000Aaron R Sasson · Sanguine Diagnostics And Therapeutics · R41 · FY2014 · CA
Evaluation of SBP-101 for the Treatment of Acute Pancreatitis
$225,000Michael Walker · Sun Biopharma, Inc. · R41 · FY2016 · DK